This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
This intro points to index funds with the highest Sharpe ratios, helping you spot leaders in risk-adjusted return efficiency.
27,038 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
AMLP offers a steady, roughly 7% yield from energy infrastructure. This article explains why most retirees overlook A...
As companies rush to deploy AI, hundreds of pilots risk wasting resources and diluting strategy. Analysts warn that t...
Brookstone Capital's 13F reveals a modest stake in the XRP ETF, but viral posts claim a $71 million position due to a...
A major enterprise contract could transform D-Wave from a hardware play into a recurring-revenue champion. This artic...
Planet Labs reports a record Q4 revenue and a backlog eclipsing annual sales, spurring a sharp after hours rally as i...
As June approaches, Netflix stock may be on the radar for investors seeking a rebound. This article highlights three ...
LNG players like Cheniere Energy have big moves ahead as expansion trains boost export capacity. This article breaks ...
NuScale Power's stock action sparks questions about small modular reactors and policy timelines. This guide breaks do...
With policy tailwinds and growing demand, the solar sector remains a core focus for 2026. Here are the best solar sto...
A major new stake in Virtu Financial is drawing attention from investors. This guide explains the numbers behind the ...
A surprise move puts a legendary director in the spotlight as a leading actor. This Tangled Up in Blue project offers...